Company Filing History:
Years Active: 2022
Title: Jorge Haller: Innovator in Hydroxy Steroid Research
Introduction
Jorge Haller is a notable inventor based in Tarrytown, NY (US). He has made significant contributions to the field of biochemistry, particularly in the study of hydroxy steroid dehydrogenases. His work focuses on developing methods for screening modulators of these important proteins.
Latest Patents
Haller holds a patent for "Assays for screening activity of modulators of members of the hydroxy steroid (17-beta) dehydrogenase (HSD17B) family." This patent outlines screening methods and kits designed to identify modulators of HSD17B family member proteins, such as HSD17B13. The methods involve screening molecules for their ability to modulate the activity of these proteins, which can be measured through various biochemical assays. The inhibitors identified through these methods have potential applications in treating liver diseases and disorders associated with HSD17B family member proteins.
Career Highlights
Jorge Haller is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to advance research in the field of hydroxy steroid dehydrogenases. His innovative approaches have contributed to the understanding of how these proteins function and their role in various medical conditions.
Collaborations
Haller has collaborated with esteemed colleagues, including Panayiotis Stevis and David Esopi. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in their field.
Conclusion
Jorge Haller's work exemplifies the impact of innovative research in biochemistry. His contributions to the understanding of hydroxy steroid dehydrogenases and the development of screening methods hold promise for future medical advancements.